ELAN
Elanco
$25.71
▼ -2.50%
−$0.66
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
· price updated 9h ago
Elanco
ELAN · NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · price updated 9h ago
$25.71
▼ -2.50% · −$0.66 today
AI research · $25.71
Track ELAN for continuous AI research
price position
Where ELAN sits now
52-week range
Low$13.39
High$27.72
Today $25.71
RSI (14)
51.7Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$428.0M
Total debt$4.0B
Net cash after debt$-3.6B
Valuation
What the market charges
Forward P/E
Price against expected earnings
Needs attention · 16% above Sector avg
24.30x
Price / sales
Value assigned to each sales dollar
Strong · Under 3x annual sales
2.69x
Price / FCF
Price against free cash generation
Rich · Above 35x free cash flow
41.81x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
23.31x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Weak · Below 8% return on capital
3.0%
ROE
Profit generated from shareholder equity
Needs attention · Among weakest in sector
-3.8%
Debt / equity
Balance-sheet leverage
Favorable · Ahead of most sector peers
0.66x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
2.16x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How ELAN compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $13.17B | - | +10.5% | 51 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Elanco (ELAN) stock
Elanco tracked in the US core universe. ELAN was -2.5% in the latest available session at $25.71. Its reported market value was $13.17B with a trailing P/E of 0.0. Latest reported revenue was $4.89B, changing +10.5% year over year, with $-242.00M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $25.71
- Day change
- -2.5%
- Market cap
- $13.17B
- P/E (TTM)
- 0.0
- Revenue growth
- +10.5%
- Industry
- Drug Manufacturers - Specialty & Generic